MarketInOut Stock Screener Log In | Sign Up
 

Anteris Technologies Global Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 05/08/2026
Anteris Technologies Global Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization632.98 mln
Float78.53 mln
Earnings Date05/19/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-8.05
Highly reliable

1-Year Forecast

15.75
Transformational upside

Relative Strength

93 / 100
Top performer

Debt / Equity

-24.54
Negative equity

ROE

-351
Deeply negative

Business Description

Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through minimally invasive procedures. Its flagship product, the DurAVR system, uses a catheter to deliver an artificial aortic valve designed to closely replicate how a healthy human valve functions. The company also develops tissue preparation technology that reduces calcium buildup in animal-derived materials used for heart surgery, along with a precision delivery tool that helps surgeons navigate the catheter safely through the heart.

Key Fundamentals

EPS-2.55
ROE-351
RPS0.05
ROIC-1,128
ROA-213
EBITDA, mln-92.49
EV / EBITDA-5.84
EV / EBIT-5.73
Revenue, mln1.91
EV / Revenue282

Financial Strength

Altman Z-Score-22.28
Piotroski F-Score 3 / 9
Beneish M-Score-8.05
1-Year Target Price15.75
Short Ratio3.96
Short % of Float6.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.46% 77 / 100   
1 Month 19.42% 85 / 100   
2 Months 10.22% 77 / 100   
6 Months 56.29% 92 / 100   
1 Year 63.28% 83 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us